Streetbeat News

Analyst Ratings

CALM

Goldman Sachs analyst Adam Samuelson has maintained a 'Sell' rating on Cal-Maine Foods (NASDAQ:CALM) and lowered the price target from $43 to $40.

Portfolio Pulse from Benzinga Newsdesk

July 07, 2023 | 10:35 am

KALV

KalVista Pharma reported Q4 losses of $(0.77) per share, beating the analyst consensus estimate of $(0.89) by 13.48 percent. This is a 21.43 percent increase over losses of $(0.98) per share from the same period last year. The company also reported cash, cash equivalents & marketable securities of $149.4M.

Portfolio Pulse from Benzinga Newsdesk

July 07, 2023 | 10:33 am

GM

Morgan Stanley analyst Adam Jonas has maintained an 'Overweight' rating on General Motors (NYSE:GM) and raised the price target from $38 to $41.

Portfolio Pulse from Benzinga Newsdesk

July 07, 2023 | 10:32 am

F

Morgan Stanley analyst Adam Jonas has maintained an Overweight rating on Ford Motor (NYSE:F) and raised the price target from $14 to $16.

Portfolio Pulse from Benzinga Newsdesk

July 07, 2023 | 10:31 am

CLH

Needham analyst James Ricchiuti maintains a 'Buy' rating on Clean Harbors (NYSE:CLH) and raises the price target from $150 to $182.

Portfolio Pulse from richadhand@benzinga.com

July 07, 2023 | 10:13 am

STGW

Needham analyst Laura Martin has reiterated a 'Buy' rating on Stagwell (NASDAQ:STGW) and maintained a $10 price target.

Portfolio Pulse from richadhand@benzinga.com

July 07, 2023 | 10:12 am

PLTK

B of A Securities analyst Omar Dessouky has upgraded Playtika Holding (NASDAQ:PLTK) from Underperform to Neutral and raised the price target from $10 to $13.

Portfolio Pulse from richadhand@benzinga.com

July 07, 2023 | 10:10 am

BIIB

HC Wainwright & Co. analyst Andrew Fein has reiterated a 'Buy' rating on Biogen (NASDAQ:BIIB) and maintained a price target of $325.

Portfolio Pulse from richadhand@benzinga.com

July 07, 2023 | 10:08 am

URG

HC Wainwright & Co. analyst Heiko Ihle has reiterated a 'Buy' rating on Ur-Energy (AMEX:URG) and maintained a price target of $2.8.

Portfolio Pulse from richadhand@benzinga.com

July 07, 2023 | 10:08 am

CRIS

HC Wainwright & Co. analyst Edward White maintains a 'Buy' rating on Curis (NASDAQ:CRIS) but has lowered the price target from $9 to $6.

Portfolio Pulse from richadhand@benzinga.com

July 07, 2023 | 10:07 am